Improved Outcomes of High-Risk Relapsed Hodgkin Lymphoma Patients After High-Dose Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Haematologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Improved Outcomes of High-Risk Relapsed Hodgkin Lymphoma Patients After High-Dose Chemotherapy: A 15-Year Analysis
Haematologica 2021 May 06;[EPub Ahead of Print], Y Nieto, S Gruschkus, BC Valdez, RB Jones, P Anderlini, C Hosing, U Popat, M Qazilbash, P Kebriaei, A Alousi, N Saini, S Srour, K Rezvani, J Ramdial, M Barnett, A Gulbis, TL Shigle, S Ahmed, S Iyer, H Lee, R Nair, S Parmar, R Steiner, B Dabaja, C Pinnix, J Gunther, B Cuglievan, K Mahadeo, S Khazal, H Chuang, R Champlin, EJ Shpall, BS AnderssonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.